A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial. ARCS Study Group. Assessment of Risperdal in a Clinical Setting.
Jeste, D V
A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial. ARCS Study Group. Assessment of Risperdal in a Clinical Setting. [electronic resource] - Psychopharmacology Jun 1997 - 239-47 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study
0033-3158
10.1007/s002130050289 doi
Adult
Aged
Dyskinesia, Drug-Induced--etiology
Female
Humans
Male
Middle Aged
Patient Compliance
Psychiatric Status Rating Scales
Quality of Life
Risperidone--adverse effects
Schizophrenia--drug therapy
A clinical evaluation of risperidone in the treatment of schizophrenia: a 10-week, open-label, multicenter trial. ARCS Study Group. Assessment of Risperdal in a Clinical Setting. [electronic resource] - Psychopharmacology Jun 1997 - 239-47 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study
0033-3158
10.1007/s002130050289 doi
Adult
Aged
Dyskinesia, Drug-Induced--etiology
Female
Humans
Male
Middle Aged
Patient Compliance
Psychiatric Status Rating Scales
Quality of Life
Risperidone--adverse effects
Schizophrenia--drug therapy